Shengnan Ren

1.1k total citations
40 papers, 809 citations indexed

About

Shengnan Ren is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shengnan Ren has authored 40 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Shengnan Ren's work include RNA modifications and cancer (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Shengnan Ren is often cited by papers focused on RNA modifications and cancer (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Shengnan Ren collaborates with scholars based in China, Türkiye and Bangladesh. Shengnan Ren's co-authors include Zhaoxia Wang, Fengqi Nie, Shuai Yan, Chenchen Wei, Ming Sun, Qinnan Chen, Pei Ma, Xin Chen, Tianwei Xu and Shanxun Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Experimental Cell Research.

In The Last Decade

Shengnan Ren

38 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengnan Ren China 14 554 405 129 72 67 40 809
Gao Liu China 14 470 0.8× 388 1.0× 133 1.0× 41 0.6× 43 0.6× 35 833
Haijun Guo China 15 401 0.7× 255 0.6× 121 0.9× 64 0.9× 32 0.5× 34 657
Mingdong Lu China 15 463 0.8× 245 0.6× 146 1.1× 131 1.8× 24 0.4× 41 719
Demetrio Gerace Italy 14 555 1.0× 285 0.7× 218 1.7× 28 0.4× 35 0.5× 25 959
Ji Sun China 15 483 0.9× 326 0.8× 131 1.0× 71 1.0× 27 0.4× 32 762
Jiateng Zhong China 13 415 0.7× 208 0.5× 235 1.8× 112 1.6× 38 0.6× 36 771
Jue Yang China 18 557 1.0× 269 0.7× 203 1.6× 97 1.3× 19 0.3× 60 933
Qianqian Lei China 16 514 0.9× 333 0.8× 213 1.7× 82 1.1× 19 0.3× 39 831

Countries citing papers authored by Shengnan Ren

Since Specialization
Citations

This map shows the geographic impact of Shengnan Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Ren more than expected).

Fields of papers citing papers by Shengnan Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Ren. The network helps show where Shengnan Ren may publish in the future.

Co-authorship network of co-authors of Shengnan Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Ren. A scholar is included among the top collaborators of Shengnan Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Ren. Shengnan Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Lan, Shengnan Ren, Shuai Xue, et al.. (2025). E-Urea-K-Based PSMA Imaging Served as an Alternative in Assessing Tumor Neovascularization via Targeting CD31. Molecular Pharmaceutics. 22(4). 2029–2039. 1 indexed citations
3.
Ren, Shengnan, et al.. (2024). Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer. Thoracic Cancer. 15(14). 1149–1163. 28 indexed citations
4.
Ren, Shengnan, Zhanyi Zhang, Mengyuan Li, et al.. (2023). Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review). International Journal of Oncology. 62(6). 13 indexed citations
5.
Ren, Shengnan, Yongli Dong, Weidong Ni, et al.. (2023). Protamine 1 as a secreted colorectal cancer-specific antigen facilitating G1/S phase transition under nutrient stress conditions. Cellular Oncology. 46(2). 357–373. 1 indexed citations
6.
Ren, Shengnan, Zhanyi Zhang, Ruijie Guo, et al.. (2023). Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer. World Journal of Gastroenterology. 29(13). 1911–1941. 7 indexed citations
7.
8.
Ren, Shengnan, et al.. (2022). The pseudogene DUXAP10 contributes to gefitinib resistance in NSCLC by repressing OAS2 expression. Acta Biochimica et Biophysica Sinica. 55(1). 81–90. 7 indexed citations
9.
Li, Yuanyuan, Shengnan Ren, Shuangbo Kong, et al.. (2022). Adgrg1 is a new transcriptional target of Hand1 during trophoblast giant cell differentiation. Journal of Reproductive Immunology. 154. 103753–103753. 1 indexed citations
10.
Liu, Zhaobang, Changjing Zuo, Zehong Yang, et al.. (2021). Radiomics model of dual-time 2-[18F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis. European Radiology. 31(9). 6983–6991. 36 indexed citations
11.
Ren, Shengnan, et al.. (2021). Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer. European Journal of Medicinal Chemistry. 221. 113543–113543. 13 indexed citations
12.
Yang, Wei, Shengnan Ren, & Jing Liang. (2021). Application and Effect of High-quality Nursing Combined with Enteral Nutrition Support in Patients with Acute Pancreatitis. 1(1). 1–1. 2 indexed citations
13.
Luo, Guoshun, Xin Lin, Shengnan Ren, et al.. (2021). Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer. European Journal of Medicinal Chemistry. 226. 113870–113870. 17 indexed citations
14.
Wu, Shuangjie, et al.. (2021). Benzothiophene derivatives as selective estrogen receptor covalent antagonists: Design, synthesis and anti-ERα activities. Bioorganic & Medicinal Chemistry. 47. 116395–116395. 12 indexed citations
15.
Yuan, Yuan, Shengnan Ren, Tiegong Wang, et al.. (2021). Differentiating T1a–T1b from T2 in gastric cancer lesions with three different measurement approaches based on contrast-enhanced T1W imaging at 3.0 T. BMC Medical Imaging. 21(1). 140–140. 1 indexed citations
16.
17.
Ren, Shengnan, et al.. (2021). Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. Molecular Therapy — Oncolytics. 23. 14–25. 39 indexed citations
18.
Wang, He, Binbin Lu, Shengnan Ren, et al.. (2019). Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44. Molecular Therapy — Nucleic Acids. 19. 218–227. 58 indexed citations
19.
Yuan, Yuan, Luguang Chen, Shengnan Ren, et al.. (2019). Diagnostic performance in T staging for patients with esophagogastric junction cancer using high-resolution MRI: a comparison with conventional MRI at 3 tesla. Cancer Imaging. 19(1). 83–83. 8 indexed citations
20.
Chen, Xin, Zhenyao Chen, Shanxun Yu, et al.. (2018). Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer. Clinical Cancer Research. 24(8). 2002–2014. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gao Liu Breakdown of academic impact, for papers by Haijun Guo Breakdown of academic impact, for papers by Mingdong Lu Breakdown of academic impact, for papers by Demetrio Gerace Breakdown of academic impact, for papers by Ji Sun Breakdown of academic impact, for papers by Jiateng Zhong Breakdown of academic impact, for papers by Jue Yang Breakdown of academic impact, for papers by Qianqian Lei
Rankless by CCL
2026